Related Experiment Video
Updated: May 24, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Ameliorated ConA-induced hepatitis in the absence of PKC-theta
Xianfeng Fang1, Ruiqing Wang, Jian Ma
1Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California, United States of America.
Abstract:
Severe liver injury that occurs when immune cells mistakenly attack an individual's own liver cells leads to autoimmune hepatitis. In mice, acute hepatitis can be induced by concanavalin A (ConA) treatment, which causes rapid activation of CD1d-positive natural killer (NK) T cells. These activated NKT cells produce large amounts of cytokines, which induce strong inflammation that damages liver tissues. Here we show that PKC-θ(-/-) mice were resistant to ConA-induced hepatitis due to essential function of PKC-θ in NKT cell development and activation. A dosage of ConA (25 mg/kg) that was lethal to wild-type (WT) mice failed to induce death resulting from liver injury in PKC-θ(-/-) mice. Correspondingly, ConA-induced production of cytokines such as IFNγ, IL-6, and TNFα, which mediate the inflammation responsible for liver injury, were significantly lower in PKC-θ(-/-) mice. Peripheral NKT cells had developmental defects at early stages in the thymus in PKC-θ(-/-) mice, and as a result their frequency and number were greatly reduced. Furthermore, PKC-θ(-/-) bone marrow adoptively transferred to WT mice displayed similar defects in NKT cell development, suggesting an intrinsic requirement for PKC-θ in NKT cell development. In addition, upon stimulation with NKT cell-specific lipid ligand, peripheral PKC-θ(-/-) NKT cells produced lower levels of inflammatory cytokines than that of WT NKT cells, suggesting that activation of NKT cells also requires PKC-θ. Our results suggest PKC-θ is an essential molecule required for activation of NKT cell to induce hepatitis, and thus, is a potential drug target for prevention of autoimmune hepatitis.
Insights
Protein kinase C-theta (PKC-θ) is crucial for natural killer T (NKT) cell development and activation, protecting against concanavalin A-induced autoimmune hepatitis in mice.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Autoimmune hepatitis involves immune cells attacking the liver, causing severe injury.
- Concanavalin A (ConA) in mice induces acute hepatitis via rapid activation of natural killer T (NKT) cells.
- Activated NKT cells release cytokines, leading to inflammation and liver damage.
Purpose of the Study:
- To investigate the role of Protein kinase C-theta (PKC-θ) in the development and activation of NKT cells.
- To determine if PKC-θ deficiency confers resistance to ConA-induced autoimmune hepatitis.
- To explore PKC-θ as a potential therapeutic target for autoimmune hepatitis.
Main Methods:
- Comparison of ConA-induced hepatitis severity in wild-type (WT) and PKC-θ knockout (PKC-θ(-/-)) mice.
- Quantification of cytokine production (IFNγ, IL-6, TNFα) in response to ConA.
- Analysis of NKT cell development and function in PKC-θ(-/-) mice, including adoptive bone marrow transfer experiments.
- Assessment of NKT cell activation upon stimulation with a specific lipid ligand.
Main Results:
- PKC-θ(-/-) mice exhibited resistance to lethal ConA doses, showing significantly reduced liver injury compared to WT mice.
- ConA-induced production of key inflammatory cytokines (IFNγ, IL-6, TNFα) was markedly lower in PKC-θ(-/-) mice.
- PKC-θ(-/-) mice displayed developmental defects in NKT cells within the thymus, leading to reduced peripheral NKT cell populations.
- Adoptive transfer of PKC-θ(-/-) bone marrow into WT mice replicated NKT cell developmental defects.
- PKC-θ(-/-) NKT cells showed impaired cytokine production upon specific lipid ligand stimulation, indicating a requirement for PKC-θ in NKT cell activation.
Conclusions:
- PKC-θ is essential for both the development and activation of NKT cells.
- PKC-θ deficiency protects against ConA-induced autoimmune hepatitis in a murine model.
- PKC-θ represents a promising therapeutic target for preventing or treating autoimmune hepatitis.
More Related Videos
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Hepatitis
Hepatic Encephalopathy
Chronic Pancreatitis I: Introduction
Acute Pancreatitis II: Pathophysiology